Viewing Study NCT02344784



Ignite Creation Date: 2024-05-06 @ 3:39 AM
Last Modification Date: 2024-10-26 @ 11:37 AM
Study NCT ID: NCT02344784
Status: UNKNOWN
Last Update Posted: 2016-08-23
First Post: 2015-01-16

Brief Title: The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder
Sponsor: HaEmek Medical Center Israel
Organization: HaEmek Medical Center Israel

Study Overview

Official Title: The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder With and Without Medication
Status: UNKNOWN
Status Verified Date: 2016-08
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PPI
Brief Summary: The purpose of this study is to show that Prepulse inhibition test of acoustic startle response is an indicator of objective diagnostic characteristics of attention deficit disorder in children and adolescents

by demonstrating that Prepulse inhibition test of acoustic startle response is impaired in children and adolescents suffering from attention deficit disorder in the relation to the normal function described in the literature

The investigators will try to prove our hypothesis by an experiment that consists of two phases

Phase I about 25 minutes

The patient will enter the room will be asked to sit on a chair and will be asked to look at a computer screen showing silent video of aquarium fish then the patient will be connected to both the Prepulse inhibition test device and the Galvanic skin response device and pass the tests

Phase II about 25 minutes

After completion of Phase I each participant will receive his daily regular dose of methylphenidate and after an hour and a half from taking the drug will repeat the tests both the Prepulse inhibition test and the Galvanic skin response test

Duration of the entire experiment is 140 minutes two hours and twenty minutes
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
0071-14 OTHER HaEmekMC None